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INTRODUCTION
Microorganisms that cause burn wound infections have changed over years related to changes made in the treatment of burn patients. Infection is a major complication of burn injury and is responsible for 50-75% of hospital deaths. A moist, thermally coagulated burn wound, with its constantly replenished supply of Burn wound healing studies diffusing serum nutrients and warm surface temperature, provides an environment suitable for rapid microbial growth. As local microbial growth increases, the potential for invasion to subjacent viable tissues and penetration into circulation increases.
Topical antibiotics can play an important role in prevention and treatment of many primary cutaneous bacterial infections commonly seen in dermatological practice like localized superficial infections due to surgery, injury, and abrasion. Topical antimicrobials help in preventing entry of microorganism into wound, which lead to fast healing of wounds. [1, 2] Norfloxacin (NF), a broad-spectrum fluoroquinolone antibacterial agent, is commonly employed in the treatment of urinary and genital tract infections. It is a hydrophilic fluoroquinolone with unique physiochemical properties such as low water solubility and partition coefficient. [3, 4] Curcuma longa is reported to possess antibacterial and anti-inflammatory activity, which are complimentary to wound healing process. [5, 6] The easy availability of C. longa, cost-effectiveness, and reduction of microbial resistance against NF; prompted us to formulate the topical formulations containing NF in combination with C. longa and to evaluate burn wound healing efficacy in comparison with marketed silver sulfadiazine 1% cream, USP. The prepared formulations also aims to evaluate whether the combination of C. longa and antibiotic produce any synergistic effect on wound healing. C. longa has been traditionally used as a wound healer in ancient days. As a result of the discovery of newer antibiotics and related chemotherapeutic agents, use of C. longa went into total obscurity. [5] Ability of microorganisms to render themselves resistant to antibiotics necessitated search for newer agents. During such efforts it was noticed that C. longa promotes wound healing even without the application of antibiotics and its activity is almost parallel to antibiotic. This observation leads to the logical reasoning that combination of Curcuma longa with an antibiotic may provide better and efficient process of wound healing.
MATERIALS AND METHODS

Materials
NF (Pfiscar India Ltd., Murthal, Haryana); All other chemicals used were of analytical grade.
Methods
Various semisolid formulations containing NF and C. longa were prepared, with different bases using standard procedures [ Table 1 ]. In each of the formulations, NF and C. longa was incorporated at 5 and 2% w/w concentration in the base with trituration using geometric dilution procedure to get a homogeneous mass. [7, 8, 9, 10] Skin irritation was tested in order to find any allergic reactions caused by the application of topical/transdermal formulations. Six rabbits of either sex weighing 1.3-1.5 kg were used in this study. The abdominal hairs were removed by shaving, selected plaster formulation containing NF were applied on to the shaved skin of each rabbit and left in contact for 23 h daily for 22 days. The skin was observed regularly for the study period for erythema (reddening of the skin), inflammation, contact dermatitis, or any change. [9] The antibacterial activity of various semisolid formulations containing NF and C. longa against various strains of aerobic and anaerobic microorganisms was evaluated by standard cup-late method. [10, 11] Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa (aerobic organisms), and Bacteriodes fragilis (anaerobic organism) were used for testing the antibacterial activity. Nutrient agar medium was used for aerobic bacterial cultures and blood agar medium was used for Bacteroides fragilis. Plates with aerobic organisms were incubated at 37 ± 0.2°C for 24 h under aerobic conditions, while Bacteroides fragilis cultures were incubated under carbon dioxide atmosphere in an anaerobic jar at 37 ± 0.2°C for 48 h. Inhibition zone diameters were measured with the help of zone reader (Digital Antibiotech Zone Reader, Effem Technologies).
The experiments were carried out as per the guidelines and prior approval of Animal Ethics Committee (KNMIPER/140305/878). Healthy Wistar albino rats weighing between 150 and 180 g were used for burn wound healing. The animals were divided into various groups, each group containing six animals. The untreated group was taken as control. The dorsum of each rat was shaved and the burn wounds were inflicted on overnight-starved animals under pentobarbitone sodium (6 mg/100 g, intraperitoneal (i.p.)), anesthesia. A 2 × 2 cm metal cylinder was placed on the shaven back of the animals. Melted wax at 80°C was poured into the metal cylinder and the wax was allowed to solidify. Eight minutes after this or until the wax was completely solidified, the metal cylinder containing wax adhering to the skin was gently removed to inflict a distinctly demarked burn wound. [12, 13] In all cases, the burns were third degree, and the percentage was in one sample unit area according to the rule of nines, that is 9% of the body surface involved.
Selected topical formulation and the marketed silver sulfadiazine 1% cream USP (500 mg) were applied to the wound inflicted areas of animals every day from day 1 until day 12. The epithelialization period was monitored by recording the number of days required for eschar to fall off from the burn wound surface without leaving a raw wound behind. The animals were observed for wound healing by measuring the wound contraction (tracing the raw wound area on a transparent polythene paper which was retraced on graph paper (to assess the area) up to 12 day post wounding. The wound contraction was calculated as percentage of original wound size for each animal of a group.
The epithelialization period and wound contraction was observed in the study. The epithelialization period was monitored by recording the number of days required for eschar to fall off from the burn wound surface without leaving a raw wound behind.
The rats were anesthetized and the burned skin tissue samples were collected from rats (day 1, 4, 8, and 12) for histopathological examinations. The samples was fixed in 10% neutral buffered formalin, and were cut into 5 μm sections and stained with hematoxylin and eosin (H and E), and examined by light microscopy for morphological changes. A histopathologist, blinded to the study was assigned to analyze and grade the histological changes of each group. [14, 15, 16, 17] 
Statistical analysis
Data pertaining to antimicrobial and burn wound healing activity were expressed as mean ± standard deviation (SD) and the data was analyzed by one-way analysis of variance (ANOVA) with Tukey's test for multiple comparisons using Jandel Sigma Stat statistical software, version 2.0. In all the analysis, P < 0.05 was considered as statistically significant.
RESULTS
Skin irritation test
The skin irritation study indicated that neither the drug nor its components caused any edema or inflammation in or around the application area during the period of study, however reddening of the skin was observed after 7 day, at the application site of formulation F . However, the reddening of the skin disappeared after the discontinuation. Reddening of the skin may be due to the presence of dimethyl sulfoxide (DMSO) in the formulation.
Antimicrobial activity
In this experiment, all the formulations produced marked antimicrobial activity as compared to silver sulfadiazine 1% cream USP as indicated by the inhibition zone diameter. Importantly, the formulations F exhibited a significant and potential inhibitory effect on the growth of various strains of aerobic and anaerobic microorganisms as compared to other formulations (P < 0.05) [ Table 2 ].
Burn wound healing activity
Mortality was not observed in the animals during the entire study period. The mean period of epithelialization for selected NF and Curcuma longa semisolid formulations was found to decrease significantly when compared to the control (P < 0.05; 36.9 ± 1.4 days). A statistically significant increase in the percent burn wound contraction was observed with selected semisolid formulations treated animals during the observation period (days 4, 8, and 12) as compared to control. All the formulations including the silver sulfadiazine 1% cream USP had shown wound healing activity (P < 0.05) in rats. Burn wound healing studies revealed a maximum percent wound healing of 85.14 ± 0.75% with F and 84.34 ± 0.49% with silver sulfadiazine formulation within 12 days [ Table 3 ].
Histopathological studies
The various histopathological changes observed during the study period (day 1, 4, 8, and 12) are tabulated in Table 4 and illustrated in Figures 1-3 .
DISCUSSION Skin irritation test
The results obtained from the skin irritation studies demonstrate the suitability of the prepared topical dosage forms.
Antimicrobial activity
Formulations containing polyethylene glycol and carbopol gel base showed better larger zones of inhibition in comparison to other dermatological base formulations, indicating the better activity of the drug. In creams, owing to their biphasic nature, partitioning of the drug occurs in two phases, resulting in slower release of drug; while in the case of gels, the drug diffusion occurred through the aqueous phase and hence they offer a greater drug diffusion and release. [7, 8] Burn wound healing activity
In the past, many studies have been done using natural products for the treatment of burn wounds, but these were mainly aimed at controlling infections. [14, 15, 17] Anti-inflammatory activity of certain natural products could also play a part in the healing of burn wounds. [17] Although the present investigation did not explore the exact mechanism of prohelaing of C. longa, it could be attributed to both anti-inflammatory and antiseptic properties. A clinical study showed that in the treatment of superficial and deep seconddegree burns, addition of another prohelaing agent like hyaluronic acid significantly overcame the disadvantages associated with silver sulphadiazine. [16, 17] Based on the above studies, we recommend that the incorporation of C. longa could significantly enrich the assortment of topical medications available on the market for the treatment of burn wounds and infection.
CONCLUSION
Formulations containing a combination of NF and C. longa were easy to prepare and prevent microorganisms recess on the wound. The antibacterial and wound healing activity of the formulations was comparable to that of the silver sulfadiazine 1% cream, USP, available in the market. Among all the semisolid formulations prepared, Carbopol gel base was found to be most suitable dermatological base in comparison with various other dermatological bases. It also has esthetic appeal, which other bases lack, an important aspect from patient compliance and consumer point of view. The therapeutic potential of such formulations may motivate researchers for its further exploitation for their commercial viability.
Figures and Tables   Table 1 Composition of topical formulations of norfloxacin (NF) and Curcuma longa Table 2 Antimicrobial activity of various selected semisolid formulations of norfloxacin and Curcuma longa Table 3 Percent burn wound contraction of various selected semisolid formulations of norfloxacin and Curcuma longa Table 4 Comparative evaluation of histopathological observations of selected norfloxacin and Curcuma longa semisolid formulations with silver sulfadiazine 1% cream, USP 
